Cartesian Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
7495 New Horizon Way, Frederick, MD

Insiders trading volume in the past year

Cartesian Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Timothy A. Springer Director, 10%+ Owner $172M +$12.5M +7.83% Nov 14, 2024
Murat Kalayoglu Director, 10%+ Owner $121M Oct 11, 2024
Elizabeth Hoge 10%+ Owner $121M Oct 11, 2024
Carsten Brunn President and CEO, Director $14.8M Jan 2, 2024
Blaine Davis Chief Financial Officer $7.45M Jan 2, 2024
Metin Kurtoglu Chief Technology Officer $1.05M -$1.44M -57.7% Nov 14, 2024
Carrie Smith Cox Director $1M Jan 2, 2024
Peter G. Traber Chief Medical Officer $931K Sep 25, 2023
Lloyd P. Johnston Chief Operations Officer $922K Jan 4, 2023
Zenner Patrick J Director $661K Jan 2, 2024
Nishan DeSilva Director $561K Jan 2, 2024
Aymeric Sallin Director $547K Jan 2, 2024
Christopher Jewell Chief Scientific Officer $514K -$875K -63% Nov 14, 2024
Takashi Kei Kishimoto Chief Scientific Officer $464K May 30, 2023
Kevin Tan Chief Financial Officer $427K Jan 3, 2022
Michael Singer Director $353K Apr 8, 2024
Milos Miljkovic Chief Medical Officer $337K -$908K -72.9% Nov 14, 2024
Timothy C. Barabe Director $282K +$95.3K +50.9% Aug 12, 2024
Goran Ando Director $59.3K Jan 2, 2023
Emily English SVP, Head of Manufacturing $26.7K Apr 9, 2024
Kemal Malik Director $14.7K Jul 1, 2024
Ann K. Donohue VP Finance $8.63K May 27, 2021
Scott Myers Director Nov 13, 2023

Recent Insider Transactions by Companies or Individuals for Cartesian Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.